Cargando…
Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
BACKGROUND: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics. Hence, determination of mutations in k-ras gene is crucial...
Autores principales: | Bagherlou, Nazanin, Farajnia, Safar, Zahri, Saber, Dastranj Tabrizi, Ali, Nazari, Atefeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992719/ https://www.ncbi.nlm.nih.gov/pubmed/32042390 http://dx.doi.org/10.22088/cjim.11.1.75 |
Ejemplares similares
-
Cytoplasmic Chaperones Enhance Soluble Expression of Anti-EGFR huscFv in Escherichia coli
por: Nazari, Atefeh, et al.
Publicado: (2020) -
CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985) -
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020) -
The effect of CA125 on metastasis of ovarian cancer: old marker new function
por: Yuan, Qin, et al.
Publicado: (2017) -
The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)